Official publication of the International Society of Neurobiology and Psychopharmacology.
Aims and scope
Annals of General Psychiatry considers manuscripts on all aspects of psychiatry, including neuroscience and psychological medicine. Both basic and clinical neuroscience contributions are encouraged.
Annals of General Psychiatry emphasizes a biopsychosocial approach to illness and health and strongly supports and follows the principles of evidence-based medicine. As an open access journal, Annals of General Psychiatry facilitates the worldwide distribution of high quality psychiatry and mental health research. The journal considers submissions on a wide range of topics including, but not limited to, psychopharmacology, forensic psychiatry, psychotic disorders, psychiatric genetics, and mood and anxiety disorders.
Featured article: Dietary total antioxidant capacity is inversely associated with depression, anxiety and some oxidative stress biomarkers in postmenopausal women
"Postmenopausal women are at higher risk of mental disorders. Oxidative stress has implication in the development of these disorders... An inverse relationship was found between dietary total antioxidant capacity (DTAC) with depression, anxiety scores and some oxidative stress biomarkers in postmenopausal women. These findings indicate DTAC may be used for developing effective dietary measures for reducing depression and anxiety in these women."
Annual Journal Metrics
2022 Citation Impact
3.7 - 2-year Impact Factor
4.1 - 5-year Impact Factor
1.549 - SNIP (Source Normalized Impact per Paper)
0.976 - SJR (SCImago Journal Rank)
15 days submission to first editorial decision for all manuscripts (Median)
131 days submission to accept (Median)
2,493 Altmetric mentions